Insys Therapeutics Declines After Replacing CEO Saeed Motahari

Tony Owusu - finance.yahoo.com Posted 5 years ago

Effective immediately, Andrew G. Long, chief financial officer, will take over as CEO, succeeding Saeed Motahari after the the two sides mutually agreed that Motahari should step down as president and CEO. "We believe that now is the right time to transition leadership and that Andy is an excellent choice to serve as the company's CEO," said board Chairman Steven Meyer. "On behalf of the Board, I thank Saeed for his commitment to Insys and meaningful contributions to the enterprise.

Story continues